Naeemikia F, Reynolds J, Dong C, Pritchard JR. Interleukin signaling mitigates the inhibitory effects of combined Src/BCR-ABL1 blockade on T-cell activity in Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica 2026; 111(7):2307-2318; https://doi.org/10.3324/haematol.2025.288829.